Sorrento Therapeutics, Inc. Quarterly Income Tax Expense (Benefit) in USD from Q1 2014 to Q2 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Sorrento Therapeutics, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q1 2014 to Q2 2023.
  • Sorrento Therapeutics, Inc. Income Tax Expense (Benefit) for the quarter ending June 30, 2023 was $671K.
  • Sorrento Therapeutics, Inc. Income Tax Expense (Benefit) for the twelve months ending June 30, 2023 was $9.31M.
  • Sorrento Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2022 was -$2.42M, a 92.8% increase from 2021.
  • Sorrento Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2021 was -$33.5M, a 1564% decline from 2020.
  • Sorrento Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2020 was -$2.01M, a 326% decline from 2019.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2023 $9.31M $671K +$1.72M Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $7.59M $11.5M +$10M +684% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-15
Q4 2022 -$2.42M -$1.81M +$31.2M +94.5% Oct 1, 2022 Dec 31, 2022 10-K 2023-03-16
Q3 2022 -$33.7M -$1.02M -$1.4M -363% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-08
Q2 2022 -$32.3M -$1.05M -$409K -63.8% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 -$31.8M $1.46M +$1.67M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 -$33.5M -$33.1M -$33.1M -91919% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-16
Q3 2021 -$425K $386K +$241K +166% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 -$666K -$641K +$1.28M +66.6% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 -$1.94M -$206K +$70K +25.4% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 -$2.01M $36K -$273K -88.4% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-16
Q3 2020 -$1.74M $145K +$366K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-05
Q2 2020 -$2.11M -$1.92M -$1.54M -401% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-06
Q1 2020 -$571K -$276K -$98K -55.1% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-05
Q4 2019 -$473K $309K +$3.43M Oct 1, 2019 Dec 31, 2019 10-K 2022-03-11
Q3 2019 -$3.91M -$221K +$605K +73.2% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 -$4.51M -$383K +$994K +72.2% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-04
Q1 2019 -$5.5M -$178K +$770K +81.2% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q4 2018 -$6.27M -$3.12M +$87.3M +96.5% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-19
Q3 2018 -$93.6M -$826K -$58.3M -101% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 -$35.3M -$1.38M +$21K +1.5% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-09
Q1 2018 -$35.3M -$948K +$748K +44.1% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-15
Q4 2017 -$36M -$90.4M -$90.4M Oct 1, 2017 Dec 31, 2017 10-K 2020-03-03
Q3 2017 $54.4M $57.5M +$57.7M Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-09
Q2 2017 -$3.29M -$1.4M -$1.4M Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 -$1.89M -$1.7M -$1.7M Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q4 2016 -$195K $0 -$1.19M -100% Oct 1, 2016 Dec 31, 2016 10-Q 2017-05-15
Q3 2016 $991K -$195K -$35.5M -101% Jul 1, 2016 Sep 30, 2016 10-Q/A 2018-02-27
Q2 2016 $36.5M $0 +$17K Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-09
Q1 2016 $36.5M $0 +$178K Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-15
Q4 2015 $36.3M $1.19M +$2.89M Oct 1, 2015 Dec 31, 2015 10-K 2018-03-16
Q3 2015 $33.4M $35.3M +$35.3M Jul 1, 2015 Sep 30, 2015 10-Q 2015-11-16
Q2 2015 -$1.9M -$17K -$17K Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-08
Q1 2015 -$1.88M -$178K -$178K Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-10
Q4 2014 -$1.7M -$1.7M Oct 1, 2014 Dec 31, 2014 10-K/A 2017-03-27
Q3 2014 $0 Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-16
Q2 2014 $0 Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-07
Q1 2014 $0 Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.